| |
 |
Pang; Peter K. T. Patents |
|
Assignee: Pang; Peter K. T.
Address: Alberta, CA
No. of patents: 5
Patents:
| Patent Number |
Title Of Patent |
Date Issued |
| 5886012 |
Method of treatment for disease associated with excessive PHF using combination therapy involvin |
March 23, 1999 |
| Hypotensive mammals are treated to lower mean blood pressure by administering synergistic amounts of a calcium blocking agent together with a calcium supplement. |
| 5457132 |
Kit used in the treatment for hypertension using combination therapy involving exogenous calcium |
October 10, 1995 |
| A kit containing benzeneacetonitrile and calcium or dihydropyridine and calcium hypertensive mammals may be treated to lower mean blood pressure by administering a calcium channel blocking agent together with one or both of a calcium supplement and Vitamin D. The hypotensive effect of th |
| 5350771 |
Method and treatment for hypertension using combination therapy involving exogenous calcium and |
September 27, 1994 |
| Hypertensive mammals may be treated to lower mean blood pressure by administering a calcium channel blocking agent together with one or both of a calcium supplement and Vitamin D. The hypotensive effect of this combination is synergistic and the dose response is more predictable than |
| 5317010 |
Parathyroid hormone analogues substituted at AA 25, 26, 27, and use in osteoporosis treatment |
May 31, 1994 |
| Analogues of bovine and human parathyroid hormone, wherein twenty-fifth, twenty-six and twenty-seventh positions of the natural hormone, Arg-Lys-Lys- each have been substituted with Ala, Asn, Asp, Cys, Gln, Glu, Gly, His, Ile, Leu, Met, Phe, Pro, Ser, Thr, Trp, Tyr or Val have been f |
| 5192664 |
Parathyroid hypertensive factor, antibodies and uses thereof |
March 9, 1993 |
| A new circulating factor from the parathyroid gland of some hypertensive mammals have been isolated and characterized. Polyclonal and monoclonal antibodies raised against this factor are usable as a screen for the presence of the factor. The factor is involved in the control of calcium |
|
|
|
